Stock RADIENT PHARMACEUTICALS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Radient Pharmaceuticals Corp

Equities

US7503411099

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Radient Pharmaceuticals Corp

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Radient Pharmaceuticals Corporation : RADIENT PHARMA Announces Reverse Stock Split
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Expands Distribution Of Onko-Sure® In Asia; Receives Payment On First Order Of 60 Kits
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Launches New Onko-Sure® Website, Facebook And Twitter Outreach
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Two Abstracts Submitted To 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility In Colorectal Cancer Are Accepted For Presentation
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Completes Restructurings With Institutional Investors To Limit Conversions And Stock Sales And Provide For Potential Additional Capital
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Asks DHS Holding Co. To Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Announces FY 2011 Third Quarter Results
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Files Patents In Japan And China
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Announces Dismisal Of Lawsuit On Its CIT Cancer Theraputic Technology
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Onko-Sure® Is National Sponser For Get Your Rear In Gear® Colorectal Cancer Grassroots Organization
PU
Radient Pharmaceuticals Corporation : RADIENT PHARMA Submits Two Abstracts To The American Society Of Clinical Oncologists On The Increased Sensitivity Of Onko-Sure® Combined With CEA For Colorectal Cancer Detection
PU
RADT PHAR : RADIENT PHARMA Ships Onko-Sure® Test Kits To Brazil And Files Patent In Brazil
PU
RADT PHAR : RADIENT PHARMA Appoints Biotech Executive Dr. Leonard Reyno To Its Board of Directors
PU
RADT PHAR : RADIENT PHARMA Onko-Sure® Cancer Test Available Through NeoloMed BioSciences
PU
RADT PHAR : RADIENT PHARMA Enters Distribution Agreement With Uni Pharma For Onko-Sure® Sales In Taiwan
PU
RADT PHAR : RADIENT PHARMA Onko-Sure® Is Proven Effective In Early Detection Of Lung Cancer
PU
RADT PHAR : RADIENT PHARMA Appoints Dilek Mir As Director Of Business Development And Investor Relations
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Radient Pharmaceuticals Corp